{ event: "article_read", name: `EVOLUTION: RWE from Saudi Arabia`, author: ``, tags: `Diabetes`, publication_date: ``, interaction_type: "content" } 
Read article
EVOLUTION: RWE from Saudi Arabia
Evaluating the clinical effectiveness and safety of insulin glargine 300 U/ml in individuals with T2D uncontrolled on Basal insulin: A real-world evidence study form Saudi Arabia (EVOLUTION).
Related articles
Challenges associated with commonly-used insulin advancement options
An educational video to discuss the challenges associated with commonly-used insulin advancement options and the need for treatment simplification for many adults with T2D. The video reviews data supporting the use of BI + GLP-1 RA FRCs versus commonly-used insulin regimens in adults with T2D.
MAT-BH-2300744/V1/NOV2023